Epilepsy News

Surgical therapy yielded lower long-term health care costs compared with medical therapy in children with drug-resistant epilepsy, according to a Canadian study published in Neurology.

Early posttraumatic seizures following moderate to severe TBI were linked to poorer in-hospital and long-term outcomes, including posttraumatic epilepsy, according to an Australian registry-based cohort study published in JAMA Neurology.

Women with epilepsy experienced significant decreases in dose-normalized concentrations of antiseizure medications during pregnancy, according to a study published in JAMA Neurology.

The FDA has granted approval to Amring Pharmaceuticals Inc. for its generic lamotrigine ODT, according to a press release.

The COVID-19 pandemic has significantly altered delivery of developmental services among children with acute provoked neonatal seizures, according to results of a prospective cohort study published in Pediatric Neurology.

The FDA granted orphan drug designation to PharmaTher for its status epilepticus ketamine treatment, according to a company press release.

Greater prevalence and severity of head injuries as one’s life span continues shows a correlation to an increased risk for late-onset epilepsy, according to a cohort study published in Neurology.

Neuroscience specialty pharmaceutical company OWP Pharmaceuticals Inc. has partnered with Eversana, a provider of global services to the life sciences industry, to launch oral liquid formulations for treating neuroscience disorders.

Although the rate of self-reporting was low, patients with posttraumatic epilepsy within 1 year of a traumatic brain injury sustained negative functional outcomes, according to a cohort study published in JAMA Network Open.

Parents commonly reported sleep concerns that persisted with age for children with early-life epilepsies, according to study results published in Pediatric Neurology.